Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

PHARMACEUTICALS

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

DAPSONE  CRS (100 MG)

DAPSONE CRS (100 MG)

80-08-0

DISCOVER
Daunorubicinone CRS, 15mg

Daunorubicinone CRS, 15mg

21794-55-8

DISCOVER
DAUNORUBICIN HYDROCHLORIDE CRS (120 MG)

DAUNORUBICIN HYDROCHLORIDE CRS (120 MG)

23541-50-6

DISCOVER
DEFEROXAMINE MESILATE CRS (30MG)

DEFEROXAMINE MESILATE CRS (30MG)

138-14-7

DISCOVER
DEHYDROHEXETIDINE CRS (50 MG)

DEHYDROHEXETIDINE CRS (50 MG)

NA

DISCOVER
DEMECLOCYCLINE HYDROCHLORIDE CRS (100 MG)

DEMECLOCYCLINE HYDROCHLORIDE CRS (100 MG)

64-73-3

DISCOVER
N-DEMETHYLERYTHROMYCIN A CRS (15 MG)

N-DEMETHYLERYTHROMYCIN A CRS (15 MG)

992-62-1

DISCOVER
DESOXYCORTONE ACETATE CRS (100 MG)

DESOXYCORTONE ACETATE CRS (100 MG)

56-47-3

DISCOVER
DEPTROPINE CITRATE CRS (60 MG)

DEPTROPINE CITRATE CRS (60 MG)

2169-75-7

DISCOVER
Dequalinium chloride CRS, 50mg

Dequalinium chloride CRS, 50mg

522-51-0

DISCOVER
Dequalinium chloride for performance test CRS, 50mg

Dequalinium chloride for performance test CRS, 50mg

522-51-0

DISCOVER
DESACETYLVINBLASTINE CRS (1 MG)

DESACETYLVINBLASTINE CRS (1 MG)

ND

DISCOVER